News
🇪🇺 EMA Page 2Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 13–24 of 353 articles
EU Pharma Package exclusivity: what to do now
European Union · 4 min
Robert KimEMA board backs Ebola response, flags 2025 annual report at June meeting
EMA · Ebola · 5 min
Robert KimEMA Tightens Liver Safety Checks for Tavneos After Fatal Cases
EMA · vasculitis · 5 min
Robert KimFDA approves capivasertib plus abiraterone and prednisone in PTEN-deficient mHSPC
FDA · prostate cancer · 6 min
James ParkChina Becomes Big Pharma's Essential R&D Partner
4 min
Robert KimMHRA targets medicine safety with new AI sandbox
MHRA · 4 min
Robert KimBioCryst’s New ORLADEYO Data Adds Real-World HAE Evidence
HAE · 6 min
James ParkEMA researchers map AI research priorities across the medicines lifecycle
EMA · 4 min
Robert KimTruqap gains US approval in PTEN-deficient metastatic prostate cancer
FDA · prostate cancer · 6 min
James ParkDuty of care at oncology conferences spotlights planetary health research
Oncology · 4 min
James ParkSynthetic real-world data reshapes oncology trial decision-making
Oncology · 4 min
James ParkEMA approved 104 human medicines in 2025: what changed
EMA · osteoporosis · 6 min
James ParkPopular topics
- Drug Approvals 1,138 articles
- Clinical Trials 652 articles
- Regulatory Updates 695 articles
- Press Releases 443 articles
- Oncology 456 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 143 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways